Qui et al. also showed that breast cancer patients with stage 0-I possess higher ASS1 expression, while those with advanced stage (III and IV) possess considerably lower ASS1 levels, suggesting the inactivation of ASS1 expression may occur during the transition from low to advanced stages of breast cancer. Here, ASS1 is linked to breast cancer.